VanDevanter, D R <br/><br/>
Rationalizing endpoints for prospective studies of pulmonary exacerbation treatment response in cystic fibrosis.  [electronic resource] 

 -  Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society  09 2017 
 - 607-615 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1873-5010 
<br/><br/><label>Standard No.: </label>10.1016/j.jcf.2017.04.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-Bacterial Agents--therapeutic use<br/>Clinical Protocols--standards<br/>Cystic Fibrosis--complications<br/>Endpoint Determination--methods<br/>Feasibility Studies<br/>Female<br/>Forced Expiratory Volume--drug effects<br/>Humans<br/>Male<br/>Outcome Assessment, Health Care--methods<br/>Randomized Controlled Trials as Topic--methods<br/>Respiratory Tract Infections--drug therapy<br/>Sample Size<br/>Surveys and Questionnaires--standards<br/>Symptom Flare Up